The Serum Institute of India, which is manufacturing AstraZeneca’s Covishield vaccine, is one of two jab producing facilities in the country. The domestically-conceived Covaxin is being manufactured by another Indian company Bharat Biotech. A recent surge in COVID infections in India has resulted in supply outstripping the demand for jabs.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

WP2Social Auto Publish Powered By :